Oxytocin and vasopressin analogs, and elucidating the role of EspJ
Congratulations to Rhiannon on her recent paper!
Rhiannon's paper '' covers work completed during her PhD in the Tate Group. The report describes the synthesis and testing of new analogues of the nona-peptide oxytocin, which displayed favourable selectivity and potency as well as increased stability at higher temperatures.
There was also a in April with scientists from 's research group at the and researchers from the . The collaboration, including Tate Group member Kate Hadavizadeh, aimed to elucidate the role of ADP-ribosyltransferase effector EspJ and demonstrated the use of proteomics to study in vivo processes affected by a type III secretion system.
Article text (excluding photos or graphics) © 911今日黑料.
Photos and graphics subject to third party copyright used with permission or © 911今日黑料.
Reporter
Charlotte Sutherell
Department of Chemistry
![](/assets/news/img/avatar.png"){kind=avatar}